COVID-19: cross-immunity of viral epitopes may influence severity of infection and immune response  

作　　者：Junaid Kashir Khaled AlKattan Ahmed Yaqinuddin 

机构地区：[1]College of Medicine,Alfaisal University,Riyadh,Kingdom of Saudi Arabia [2]Department of Comparative Medicine,King Faisal Specialist Hospital and Research Center,Riyadh,Kingdom of Saudi Arabia

出　　处：《Signal Transduction and Targeted Therapy》2021年第4期1071-1072,共2页信号转导与靶向治疗（英文）

基　　金：This work was supported by a COVID-19 project grant(#951)awarded by the Saudi Arabian Ministry of Health awarded to JK,KAK,and AY.

摘　　要：A recent study published in Science by Shrock et al.1 examined how responses to COVID-19 severity differed amongst patients with different prior viral exposure history,finding notable correlations between both.Such serological profiling provides a window into differential viral responses amongst patients with diverse outcomes,potentially mediating improved therapeutics and vaccines for SARS-CoV-2.

关 键 词：SEVERITY IMMUNITY al. 

分 类 号：R563.1[医药卫生—呼吸系统]